The experiments in this proposal are designed to identify and characterize T cell costimulatory pathways that prevent the induction of peripheral T cell anergy or cell death as a consequence of T cell antigen receptor (TCR) engagement. It is believed that under most circumstances TCR-mediated signal transduction serves primarily to activate a T cell to a state where the cell must make a further decision to proliferate and acquire effector function; be rendered anergic; or induced to die by apoptosis. Which fate the cell chooses is determined by accessory or costimulatory signals received by the cell either at the same time as TCR engagement or shortly thereafter. One candidate costimulatory pathway has been defined which is mediated by the CD28 receptor on the T cell interacting with its ligand B7 on the antigen-presenting cell (APC). To examine the role of the B7/CD28 activation pathway in the regulation of peripheral T cell responses, CD28-deficient mice have been produced. The ability to induce peripheral tolerance in response to various forms of antigenic challenge will be examined using these CD28-deficient mice in order to determine the significance of CD28 in various forms of immune response. By studying the responses of CD28-deficient T cells to antigen presentation by individual types of APCs, we hope to identify additional costimulatory pathways and determine their role in inducing/preventing peripheral tolerance. As part of these studies, the molecular mechanisms by which costimulatory signals prevent antigen-receptor desensitization and promote IL-2 production will be investigated. Other mechanisms by which costimulatory pathways may affect a peripheral immune response will also be explored. For example, we have found that CD28 costimulation can enhance survival of cells activated through the TCR. This effect was independent of the ability of CD28 costimulation to enhance IL-2 production. As a result of these observations, a novel CD28-inducible gene, bci-x, has been identified which is closely related to bcl-2. The ability of different costimulators to induce bcl-x expression and enhance cell survival will also be examined. As a result of these studies, we hope to define specific strategies to regulate peripheral T cell tolerance through the modulation of T cell costimulatory signals.

Project Start
Project End
Budget Start
Budget End
Support Year
2
Fiscal Year
1994
Total Cost
Indirect Cost
Name
University of Chicago
Department
Type
DUNS #
225410919
City
Chicago
State
IL
Country
United States
Zip Code
60637
Bour-Jordan, Hélène; Esensten, Jonathan H; Martinez-Llordella, Marc et al. (2011) Intrinsic and extrinsic control of peripheral T-cell tolerance by costimulatory molecules of the CD28/?B7 family. Immunol Rev 241:180-205
McClymont, Stephanie A; Putnam, Amy L; Lee, Michael R et al. (2011) Plasticity of human regulatory T cells in healthy subjects and patients with type 1 diabetes. J Immunol 186:3918-26
Bour-Jordan, Hélène; Bluestone, Jeffrey A (2009) Regulating the regulators: costimulatory signals control the homeostasis and function of regulatory T cells. Immunol Rev 229:41-66
Bluestone, Jeffrey A; Kuchroo, Vijay (2009) Autoimmunity. Curr Opin Immunol 21:579-81
Eagar, Todd N; Turley, Danielle M; Padilla, Josette et al. (2004) CTLA-4 regulates expansion and differentiation of Th1 cells following induction of peripheral T cell tolerance. J Immunol 172:7442-50
Eagar, Todd N; Karandikar, Nitin J; Bluestone, Jeffrey A et al. (2002) The role of CTLA-4 in induction and maintenance of peripheral T cell tolerance. Eur J Immunol 32:972-81
Bour-Jordan, Helene; Blueston, Jeffrey A (2002) CD28 function: a balance of costimulatory and regulatory signals. J Clin Immunol 22:1-7
Rulifson, Ingrid C; Szot, Gregory L; Palmer, Ed et al. (2002) Inability to induce tolerance through direct antigen presentation. Am J Transplant 2:510-9
Gajewski, T F; Fallarino, F; Fields, P E et al. (2001) Absence of CTLA-4 lowers the activation threshold of primed CD8+ TCR-transgenic T cells: lack of correlation with Src homology domain 2-containing protein tyrosine phosphatase. J Immunol 166:3900-7
O'Herrin, S M; Slansky, J E; Tang, Q et al. (2001) Antigen-specific blockade of T cells in vivo using dimeric MHC peptide. J Immunol 167:2555-60

Showing the most recent 10 out of 66 publications